Select all the dates you'd like to sign-up for and click "Sign Up"
Managed Care Review Board®: New Guidelines, Treatment Options, and Benefit Management Strategies for Eosinophilic Esophagitis
Jointly provided by
This activity is supported by independent educational grants from Regeneron Pharmaceuticals, Inc, Sanofi, and Takeda Pharmaceuticals U.S.A., Inc.